Thank you for sharing!

Your article was successfully shared with the contacts you provided.
WASHINGTON — Barrett Thornhill, the former director of government relations at the Biotechnology Industry Organization (BIO), has joined Foley Hoag as a health policy specialist in the firm’s Government Strategies practice in Washington. At BIO, Barrett was responsible for the development and implementation of the organization’s legislative efforts in the U.S. Senate, covering issues such as Medicare, Medicaid reimbursement, follow-on biologic legislation and patent reform legislation. BIO is comprised of more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. Prior to his work with BIO, Barrett worked in the office of U.S. Senator Mike Crapo, R-Idaho, as his health policy legislative assistant. “We are excited to welcome Barrett to the firm, and value his deep roots in the life sciences industry, an area in which we have significant experience,” said Nick Littlefield, head of the firm’s Government Strategies practice. “Barrett will provide clients with value-added perspective on legislative and regulatory developments affecting the life sciences sector and will also work with clients on regulatory challenges confronting their specific products and new technologies.” Foley Hoag’s Government Strategies Practice is active on both the state and federal levels. Lawyers in the practice, located in Boston and Washington, work with clients in regulated industries to achieve mutually beneficial solutions to public policy issues. Foley Hoag’s Government Strategies lawyers have worked in senior-level positions within presidential administrations, on Capitol Hill, in regulatory agencies, and in industry trade associations. Thornhill received his undergraduate degree from Dartmouth College and is expecting his J.D. from Georgetown Law School.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.